Prozac ‘no better than placebo’ for treating children with depression, new review of trial data concluded

Prozac appears to be no better than placebo for treating depression in children and teens; a new study proposes novelty bias and reduced expectancy effects as explanations for the loss of efficacy.

Many researchers not compliant with published data sharing statement (2022)

Many researchers were not compliant with their published data sharing statement

Our new study shows that data availability statements are not very useful; 1670 (93%) authors who indicated that data are available on request either did not respond or declined to share their data with us

Meta-analyses with industry involvement are massively published and report no caveats for antidepressants

Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor